Skip to main content

Advertisement

SpringerLink
Log in

The Economic Cost of Rising Non-communicable Diseases in India: A Systematic Literature Review of Methods and Estimates

  • Systematic Review
  • Published:
Applied Health Economics and Health Policy Aims and scope Submit manuscript

Abstract

Background and Objectives

India has one of the world’s highest proportions of out-of-pocket expenditure (OOPE) payments. The low share of public health expenditure coupled with the double burden of disease (communicable and non-communicable) has a direct financial impact on individual OOPE and an indirect impact in the form of decreasing life expectancy, reduced productivity, and hence a negative impact on economic growth. This systematic review aims to compare and assess the estimated economic cost of non-communicable diseases (NCDs) in India and ascertain the methods used to derive these estimates.

Methods

This paper reviews the past 12-year (2010–22) literature on the economic impact of health shocks due to NCDs. Three databases were searched for the literature: PubMed, Scopus, and Google Scholar. Thematic analysis has been performed to analyse the findings of the study.

Results

The OOPE was very high for NCDs. The increasing cost was high and unaffordable, pushing many people into financial distress measured by catastrophic payments and rising impoverishment.

Conclusion

The results indicate both the direct and indirect impact of NCDs, but the indirect burden of loss of employment and productivity, despite its relevance, has been less studied in the literature. A robust economic analysis will allow an evidence-based policy decision perspective to reduce the rising burden of NCDs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. ‘WHO factsheet on non-communicable diseases (April 2021)’. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. Accessed 2 May 2022.

  2. Budreviciute A, et al. Management and prevention strategies for non-communicable diseases (NCDs) and their risk factors. Front Public Health. 2020;8:788.

  3. Yadav J, Allarakha S, Menon GR, John D, Nair S. Socioeconomic impact of hospitalisation expenditure for treatment of noncommunicable diseases in India: a repeated cross-sectional analysis of national sample survey data, 2004 to 2018. Value Health Reg Issues. 2021;24:199–213.

    Article  PubMed  Google Scholar 

  4. Nethan S, Sinha D, Mehrotra R. Non communicable disease risk factors and their trends in India. Asian Pac J Cancer Prev. 2017;18(7):2005.

    PubMed  PubMed Central  Google Scholar 

  5. Prabhakaran D, et al. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health. 2018;6(12):e1339–51.

    Article  Google Scholar 

  6. Asma S, et al. Monitoring the health-related sustainable development goals: lessons learned and recommendations for improved measurement. Lancet. 2020;395(10219):240–6.

    Article  PubMed  Google Scholar 

  7. Dandona L, et al. Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study. Lancet. 2017;390(10111):2437–60.

    Article  Google Scholar 

  8. Taylor DW. The burden of non-communicable diseases in India. Glasgow: Cameron Institute; 2010.

    Google Scholar 

  9. Pandey SK, Sharma V. World diabetes day 2018: battling the emerging epidemic of diabetic retinopathy. Indian J Ophthalmol. 2018;66(11):1652.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Abegunde DO, Mathers CD, Mathers C. Chronic diseases 1 the burden and costs of chronic diseases in low-income and middle-income countries. www.thelancet.com. 370:929–1967. https://doi.org/10.1016/S0140.

  11. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. The Lancet. 1997;349(9064):1498–504.

  12. Government of India Ministry of Health and Family Welfare. Report of National Health Account Estimates for India for 2017–18.

  13. Gupta I, Ranjan A. Public expenditure on non-communicable diseases and injuries in India: a budget-based analysis. PLoS ONE. 2019. https://doi.org/10.1371/journal.pone.0222086.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Domestic general government health expenditure (GGHE-D) as percentage of gross domestic product (GDP) (%). https://www.who.int/data/gho/data/indicators/indicator-details/GHO/domestic-general-government-health-expenditure-(gghe-d)-as-percentage-of-gross-domestic-product-(gdp)-(-). Accessed 4 Feb 2023.

  15. McKeown RE. The epidemiologic transition: changing patterns of mortality and population dynamics. Am J Lifestyle Med. 2009;3(1_suppl):19S-26S.

    Article  PubMed  Google Scholar 

  16. de Mello LF, de Paula SA. Challenges of demographic and epidemiological transitions. In: No Poverty. 2020. p. 69–79. https://doi.org/10.1007/978-3-319-95714-2.

  17. Bloom DE et al. Economics of non-communicable diseases in India: the costs and returns on investment of interventions to promote healthy living and prevent, treat, and manage NCDs. In: World economic forum. Harvard School of Public Health; 2014. p. 22–3.

  18. Bloom DE, et al. The macroeconomic impact of non-communicable diseases in China and India: estimates, projections, and comparisons. J Econ Ageing. 2014;4:100–11.

    Article  Google Scholar 

  19. Keane M, Thakur R. Health care spending and hidden poverty in India. Res Econ. 2018;72(4):435–51. https://doi.org/10.1016/j.rie.2018.08.002.

    Article  Google Scholar 

  20. Balarajan Y, Selvaraj S, Subramanian SV. Health care and equity in India. Lancet. 2011;377(9764):505–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Yadav J, John D, Menon G. Out of pocket expenditure on tuberculosis in India: do households face hardship financing? Indian J Tuberc. 2019;66(4):448–60. https://doi.org/10.1016/j.ijtb.2019.02.016.

    Article  PubMed  Google Scholar 

  22. Behera S, Pradhan J. Uneven economic burden of non-communicable diseases among Indian households: a comparative analysis. PLoS ONE. 2021;16(12): e0260628.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Menon GR, Yadav J, John D. Burden of non-communicable diseases and its associated economic costs in India. Soc Sci Humanities Open. 2022;5(1): 100256.

    Article  Google Scholar 

  24. Verma VR, Kumar P, Dash U. Assessing the household economic burden of non-communicable diseases in India: evidence from repeated cross-sectional surveys. BMC Public Health. 2021;21(1):1–22.

    Article  Google Scholar 

  25. Wagstaff A, O’Donnell O, van Doorslaer E, Lindelow M. Analyzing health equity using household survey data: a guide to techniques and their implementation. Washington: World Bank Publications; 2007.

    Google Scholar 

  26. Joshi A, Mohan K, Grin G, Perin DMP. Burden of health care utilization and out-of-pocket costs among individuals with NCDs in an Indian setting. J Community Health. 2013;38(2):320–7. https://doi.org/10.1007/s10900-012-9617-1.

    Article  PubMed  Google Scholar 

  27. Joseph N, Gupta S. Assessment of economic impact among in-patients with non-communicable diseases in a private tertiary care hospital in Southern India. J Clin Diagn Res. 2016;10(6):LM04–6. https://doi.org/10.7860/JCDR/2016/19426.8059.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Binnendijk E, Koren R, Dror DM. Can the rural poor in India afford to treat non-communicable diseases. Trop Med Int Health. 2012;17(11):1376–85.

    Article  PubMed  Google Scholar 

  29. Yadav J, Menon GR, John D. Disease-specific out-of-pocket payments, catastrophic health expenditure and impoverishment effects in India: an analysis of National Health Survey data. Appl Health Econ Health Policy. 2021;19(5):769–82. https://doi.org/10.1007/s40258-021-00641-9.

    Article  PubMed  Google Scholar 

  30. Singh P, Kumar V. The rising burden of health care expenditure in India: a poverty nexus. Soc Indic Res. 2017;133(2):741–62.

    Article  Google Scholar 

  31. Kastor A, Mohanty SK. Disease and age pattern of hospitalisation and associated costs in India: 1995–2014. BMJ Open. 2018;8(1): e016990.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Kastor A, Mohanty SK. Disease-specific out-of-pocket and catastrophic health expenditure on hospitalization in India: do Indian households face distress health financing? PLoS ONE. 2018;13(5):e0196106.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Tripathy JP, et al. Cost of hospitalisation for non-communicable diseases in India: are we pro-poor? Trop Med Int Health. 2016;21(8):1019–28.

    Article  CAS  PubMed  Google Scholar 

  34. Barik D, Arokiasamy P. Rising health expenditure due to non-communicable diseases in India: an outlook. Front Public Health. 2016;4:268.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Pati S, et al. Non communicable disease multimorbidity and associated health care utilization and expenditures in India: cross-sectional study. BMC Health Serv Res. 2014;14(1):1–9.

    Article  Google Scholar 

  36. Mahal A, Karan A, Engelgau M. The economic implications of non-communicable disease for India. Health, Nutrition and Population (HNP) discussion paper; © World Bank, Washington, DC. 2010;8. https://openknowledge.worldbank.org/handle/10986/13649.

  37. Yadav P, Kulkarni VS, Gaiha R. Growing burden of non-communicable diseases in India. University of Pennsylvania Population Center Working Paper (PSC/PARC), 2018;20. https://repository.upenn.edu/psc_publications/20.

  38. Kumar, et al. Socio-economic differentials in impoverishment effects of out-of-pocket health expenditure in China and India: evidence from WHO SAGE. PLoS ONE. 2015;10(8): e0135051.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Engelgau M, Karan A, Mahal A. The economic impact of non-communicable diseases on households in India. Glob Health. 2012;8(1):1–10.

    Article  Google Scholar 

  40. Kulkarni VS, Kulkarni VS, Gaiha R. Employment, aging and disease in India. University of Pennsylvania Population Center Working Paper (PSC/PARC), 2019;29. https://repository.upenn.edu/psc_publications/29.

  41. Agarwal A, Lubet A, Chen S, Khoury AKA, Bloom DE. Non-communicable diseases and their macroeconomic impact in India. Econ Polit Wkly. 2021;56(51):56–63.

    Google Scholar 

  42. Menon GR, et al. National burden estimates of healthy life lost in India, 2017: an analysis using direct mortality data and indirect disability data. Lancet Glob Health. 2019;7(12):e1675–84.

    Article  PubMed  Google Scholar 

  43. Taylor PN, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14(5):301–16.

    Article  PubMed  Google Scholar 

  44. Mahal A, Karan A, Fan VY, Engelgau M. The economic burden of cancers on Indian households. PLoS ONE. 2013;8(8): e71853.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Karan A, Engelgau M, Mahal A. The household-level economic burden of heart disease in India. Trop Med Int Health. 2014;19(5):581–91.

    Article  PubMed  Google Scholar 

  46. Jaspers L, et al. The global impact of non-communicable diseases on households and impoverishment: a systematic review. Eur J Epidemiol. 2014;30(3):163–88. https://doi.org/10.1007/s10654-014-9983-3.

    Article  PubMed  Google Scholar 

  47. Muka T, et al. The global impact of non-communicable diseases on health care spending and national income: a systematic review. Eur J Epidemiol. 2015;30(4):251–77. https://doi.org/10.1007/s10654-014-9984-2.

    Article  PubMed  Google Scholar 

  48. Rajpal S, Kumar A, Joe W. Economic burden of cancer in India: evidence from cross-sectional nationally representative household survey, 2014. PLoS ONE. 2018;13(2): e0193320.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Gwatidzo SD, Stewart Williams J. ‘Diabetes mellitus medication use and catastrophic health care expenditure among adults aged 50 + years in China and India: results from the WHO study on global AGEing and adult health (SAGE). BMC Geriatr. 2017;17(1):1–15.

    Article  Google Scholar 

  50. Nagarathna R, et al. Cost of management of diabetes mellitus: a pan India study. Ann Neurosci. 2020;27(3–4):190–2.

    Article  PubMed  Google Scholar 

  51. Patel S, Ram F, Patel SK, Kumar K. Cardiovascular diseases and health care expenditure (HCE) of inpatient and outpatient: a study from India Human Development Survey. Clin Epidemiol Glob Health. 2020;8(3):671–7.

    Article  Google Scholar 

  52. Dhankhar A, Kumari R, Bahurupi YA. Out-of-pocket, catastrophic health expenditure and distress financing on non-communicable diseases in India: a systematic review with meta-analysis. Asian Pac J Cancer Prev. 2021;22(3):671–80. https://doi.org/10.31557/APJCP.2021.22.3.671.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Gupta I, Roy A. Economic studies on non-communicable diseases and injuries in India: a systematic review. Appl Health Econ Health Policy. 2018;16(3):303–15. https://doi.org/10.1007/s40258-018-0370-1.

    Article  PubMed  Google Scholar 

  54. Reich MR. World bank, world development report 1993: investing in health. Econ Dev Cult Change. 1997;45:899–903.

    Article  Google Scholar 

  55. Vos T, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Economics and Finance, Birla Institute of Technology and Science, Pilani, Pilani Campus, Pilani, Rajasthan, 333031, India

    Varsha Shukla & Rahul Arora

Authors
  1. Varsha Shukla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rahul Arora
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Varsha Shukla.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Funding source

No funding was received for this research.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication (from patients/participants)

Not applicable.

Availability of data and material

The data used in analyses were generated by examining full-text papers from PubMed and Scopus. The paper was located using Google Scholar and ScienceDirect in case of the unavailability of full-length articles from the above database.

Code availability

Not applicable.

Authors’ contributions

Both authors have identified the research questions and selected studies based on inclusion and exclusion criteria. Ms VS has defined the inclusion and exclusion criteria, extracted the data from the studies, analyzed the data, and wrote the manuscript. Dr RA has provided critical comments and suggestions to arrive at the final manuscript.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 22 KB)

Appendices

Appendix 1

See Table

Table 5 Study inclusion criteria
Full size table

5.

Appendix 2

See Table

Table 6 Disease category and data source
Full size table

6.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shukla, V., Arora, R. The Economic Cost of Rising Non-communicable Diseases in India: A Systematic Literature Review of Methods and Estimates. Appl Health Econ Health Policy 21, 719–730 (2023). https://doi.org/10.1007/s40258-023-00822-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40258-023-00822-8

Search

Navigation